EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer is a research paper published in Cancer Discovery (2020). On theSindex it has a DataRank of 0. It has been cited 493 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Associazione Italiana per la Ricerca sul Cancro
Grant: 20697
Associazione Italiana per la Ricerca sul Cancro
Grant: 21407
Associazione Italiana per la Ricerca sul Cancro
Grant: 22802
AIRC
Grant: IG 2018-ID 21923
AIRC
Grant: 2018-ID 21091
European Research Council
Grant: 724748
The functional interaction of EGFR and beta-catenin signalling in colorectal cancer: Genetics, mechanisms, and therapeutic potential.
H2020
Grant: 754923
Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions
H2020
Grant: 731105
EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts
AIRC CRUK AECC
Grant: 22795
AIRC
Grant: 2017 ID 20236
NIH
Grant: R01 CA233736
Cancer Center Core
Grant: P30 CA008748
Cancer Research UK
Grant: 18052
NCI NIH HHS
Grant: R35 CA210085
NCI NIH HHS
Grant: P01 CA129243
NCATS NIH HHS
Grant: UL1 TR002384
NIH HHS
Grant: U54 OD020355
NCATS NIH HHS
Grant: UL1 TR000457
National Institutes of Health
Grant: 1R01CA233736-01
Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 3UL1TR000457-08S1
Clinical and Translational Science Center
FWCI
18.63
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals